Table 2.

Effect of HLA match on transplant outcomes (N=304)^*

Clinical endpoint	HLA Match	N	Events	Hazard ratio	95% CI	p
OS	11/12	166	50
	10/12	65	30	1.68	1.07 -2.64	0.02
	12/12	73	32	1.61	1.03 -2.51	0.04
EFS	11/12	166	64
	10/12	65	33	1.47	0.96-2.24	0.07
	12/12	73	40	1.66	1.12-2.47	0.01
CIR	11/12	166	30
	10/12	65	14	1.25	0.66-2.35	0.50
	12/12	73	24	2.02	1.18-3.47	0.01
NRM	11/12	166	34
	10/12	65	19	1.48	0.84-2.59	0.17
	12/12	73	16	1.09	0.61-1.96	0.76
Acute GvHD II-IV	11/12	165	66
	10/12	65	35	1.43	0.95-2.15	0.09
	12/12	72	27	0.92	0.59-1.44	0.72
Acute GvHD III-IV	11/12	165	22
	10/12	65	14	1.57	0.79-3.13	0.20
	12/12	73	11	1.14	0.55-2.36	0.73
Chronic GvHD	11/12	164	119
	10/12	65	48	1.19	0.84-1.69	0.32
	12/12	73	47	0.84	0.60-1.19	0.33

^*All models are multivariable and adjusted for age (<58 vs. ≥58) and disease risk (high, intermediate, low/non-malignant). Patients with incomplete clinical data or with disease risk of other were excluded.